2. Academic Validation
  3. Sphingomyelin and ceramide are physiological ligands for human LMIR3/CD300f, inhibiting FcεRI-mediated mast cell activation

Sphingomyelin and ceramide are physiological ligands for human LMIR3/CD300f, inhibiting FcεRI-mediated mast cell activation

  • J Allergy Clin Immunol. 2014 Jan;133(1):270-3.e1-7. doi: 10.1016/j.jaci.2013.08.008.
Kumi Izawa 1,  Masamichi Isobe 2,  Toshihiro Matsukawa 2,  Shinichi Ito 2,  Akie Maehara 2,  Mariko Takahashi 2,  Yoshinori Yamanishi 2,  Ayako Kaitani 2,  Toshihiko Oki 3,  Ko Okumura 4,  Toshio Kitamura 5,  Jiro Kitaura 6
Affiliations

Affiliations

  • 1 Division of Cellular Therapy, The Institute of Medical Science, University of Tokyo, Tokyo, Japan; Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan.
  • 2 Division of Cellular Therapy, The Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • 3 Division of Cellular Therapy, The Institute of Medical Science, University of Tokyo, Tokyo, Japan; Division of Stem Cell Signaling, The Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • 4 Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan; Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan.
  • 5 Division of Cellular Therapy, The Institute of Medical Science, University of Tokyo, Tokyo, Japan; Division of Stem Cell Signaling, The Institute of Medical Science, University of Tokyo, Tokyo, Japan. Electronic address: [email protected].
  • 6 Division of Cellular Therapy, The Institute of Medical Science, University of Tokyo, Tokyo, Japan. Electronic address: [email protected].
PMID: 24035150 DOI: 10.1016/j.jaci.2013.08.008
Figures